Beta-N-acetyl glucosaminidase (NAG) is a lyosomal enzyme found in high concentrations in the epithelial cells of renal tubules. It is excreted in the urine of normal people, but much larger quantities are excreted by patients with renal disease,' those taking nephrotoxic drugs,' and those starting treatment with aspirin.3 Measuring NAG excretion may be a convenient way of assessing early damage to renal tubules: the output rises sharply within a few days of the onset of the insult. The present study used NAG excretion to explore the possibility that non-steroidal anti-inflammatory drugs other than aspirin might also damage renal tubules. Enzyme excretion was also monitored in patients with rheumatoid arthritis receiving long-term treatment with D-penicillamine or levamisole.
Renal damage during treatment with antirheumatic drugs Beta-N-acetyl glucosaminidase (NAG) is a lyosomal enzyme found in high concentrations in the epithelial cells of renal tubules. It is excreted in the urine of normal people, but much larger quantities are excreted by patients with renal disease,' those taking nephrotoxic drugs,' and those starting treatment with aspirin.3 Measuring NAG excretion may be a convenient way of assessing early damage to renal tubules: the output rises sharply within a few days of the onset of the insult. The present study used NAG excretion to explore the possibility that non-steroidal anti-inflammatory drugs other than aspirin might also damage renal tubules. Enzyme excretion was also monitored in patients with rheumatoid arthritis receiving long-term treatment with D-penicillamine or levamisole.
Methods and results
Normal subjects, or patients with osteoarthritis but no renal disease or hypertension, were included in the first study. Aliquots of urine were obtained before giving the drugs, and again at intervals during the course of treatment. The drugs studied were aspirin, diflunisal, indomethacin, ibuprofen, naproxen, and azopropazone in their usual therapeutic doses. Aspirin and diflunisal were tested in both high-and low-dose regimens. In a second study, patients with rheumatoid arthritis starting treatment with D-penicillamine or levamisole were observed for intervals up to six months. Measurements of disease activity were observed over the same period. Specimens were stored at 4°C before analysis by the fluorimetric method of Tucker et al.4 The results are shown in the 
Patients and results
A total of 38 men and 25 women (age range 17-49) with functioning renal grafts were studied. They had been transplanted two months to 11 years previously and the kidneys used were predominantly from cadaveric donors. The diagnosis of avascular necrosis was based on radiological findings. Some 22 patients (34 9 %) had radiological evidence of avascular necrosis of bone, the prevalence being higher in men (16/38) than in women (6/25). The duration of renal failure and length of dialysis treatment before transplantation were similar in patients with and without avascular necrosis. Graft rejection episodes, which required increase of the dose of steroids, occurred in all but two patients. The incidence was 2-5 per patient for those who had avascular necrosis and 2-09 for those who did not (not significant). Each rejection episode was treated with 3-6 g of prednisolone over 30 days. 
